Newsletters

AstraZeneca’s digital health strategy. Pear and Cognoa studies.

4.03.20

7 min. Read

Orexo prices DTx at $600 to $1,000. Pear: $1,000 to $1,600.

3.27.20

5 min. Read

Genentech-Roche VR for autism. FDA’s new remote monitoring waiver.

3.20.20

7 min. Read

Verily paid Sanofi $122M. ResMed MitiGait. Happify Kopa.

3.12.20

6 min. Read

RCT shows no effect for AI coach. Livongo ups enrollment rate.

3.06.20

8 min. Read

Strip companies tried to kill Livongo. Sanofi DTx distro.

2.28.20

8 min. Read

FDA asks Congress for new SaMD pathway. Headspace $93M.

2.14.20

6 min. Read

Google’s EHR patient notification idea. Bayer-One Drop. Novartis-Pear.

2.07.20

6 min. Read

M&A multiples. Verily FDA. Hires: Otsuka, Astellas, Sanofi, Sandoz.

1.24.20

4 min. Read

Pear oncology. Omada schizophrenia. Noom’s $247M.

1.17.20

5 min. Read